IMPORTANT INFORMATION

This website is no longer being updated.

NHS Sheffield Clinical Commissioning Group has been legally dissolved and from 1 July 2022 has been replaced by a new organisation: NHS South Yorkshire Integrated Care Board (SY ICB). NHS South Yorkshire ICB is now responsible for commissioning and funding of health and care services locally. Please go to our new website www.southyorkshire.icb.nhs.uk for information about the work of NHS South Yorkshire ICB and details about how to contact us.

Thank you.

We want you to have more care closer to your home...

0199FOI2021

FOI Ref: 0199FOI1920

12th February 2020

Freedom of Information Act 2000 – Request for Information

We are pleased to respond to your request for information and our response is set out below:

Request

Which three drugs from this list did you spend the most on in the last financial year (2018/19)? For those three drugs please specify the total amount spent.

  • Ariprazole
  • Buspirone
  • Clomipramine
  • Escitalopram
  • Fluoxetine
  • Mirtazapine
  • Quetiapine
  • Sertraline
  • Venlafaxine

Response

Financial Year BNF Chemical Substance Items Actual Cost
2018/19 Quetiapine 23059 £288,596.25
2018/19 Fluoxetine Hydrochloride 103182 £198,827.12
2018/19 Sertraline Hydrochloride 190052 £175,453.78

 

 

NHS Sheffield Clinical Commissioning Group

Headquarters
722 Prince of Wales Road
Sheffield
S9 4EU

Logo: Facebook Logo: Twitter Logo: Youtube Logo: Pinterest